A.O. Ospedali Riuniti Villa Sofia-Cervello - Divisione di Ematologia

Running trials

• Recruiting

  PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma

  NCT07256158· Phase 3· Source

• Recruiting

  Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

  NCT07453095· Phase 2· Source

• Not yet recruiting

  PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma

  NCT07207785· Phase 2· Source

• Active, not recruiting

  Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients

  NCT06492837· Phase 2· Source

• Recruiting

  Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial

  NCT05816850· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Mantle cell lymphoma2 recruiting
• Follicular lymphoma1 recruiting
• Hodgkin lymphoma1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma

  NCT05966233· Phase 2· Source

• Completed

  Circulating Tumor DNA Genotyping for Biological Monitoring of Patients Treated in the FIL-Rouge Clinical Trial

  NCT05066555· Source

• Completed

  FIL Study on ABVD DD-DI as Upfront Therapy in HL.

  NCT03159897· Phase 3· Source